Caricamento...
Post Hoc Analysis of the Phase II/III APRIL‐SLE Study: Association Between Response to Atacicept and Serum Biomarkers Including BLyS and APRIL
OBJECTIVE: To assess the relationship between treatment response, baseline biomarker levels, and atacicept exposure in patients with systemic lupus erythematosus (SLE) in the phase II/III APRIL‐SLE study. METHODS: We performed a post hoc analysis of patients who received placebo, atacicept 75 mg, or...
Salvato in:
| Pubblicato in: | Arthritis Rheumatol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6681010/ https://ncbi.nlm.nih.gov/pubmed/27390168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39809 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|